Last update :
28/04/2024
InfoStab
Infostab
List of drugs
List of drugs
Summary lists
Summary lists
Search for compatibilities
Search for compatibilities
Y-site compatibility table
Y-site compatibility table
References
References
Research teams
Research teams
Valistab
Valistab
Poster
Poster
Links
Links
Sponsors
Sponsors
Authors
Authors
User’s guide
User’s guide
Newsletter
Newsletter
Electrolyte   Magnesium sulfate  
Injection
Stability in solutions Stability of mixtures Factors which affect stability Compatibility Route of administration References Pdf
   Chemical structure  

Tradename   Tradename     

Trade names are indicative and excipients composition can be different depending on the country and manufacturers
Addex magnesium Iceland, Norway, Sweden
Addex magnesium sulfaatii Finland
Conducat Mexico
Infu Magnesol Iran
Magnefusin Mexico
Magnesium sulfate Australia, Belgium, Canada, France, Saudi Arabia, United States of America
Magnesium sulphate Great Britain
Magneso solfato Italy
Magnezium sulfat Turkey
Magvital Austria
Solfato de magnesio Argentina, Chile, Ecuador, Peru, Venezuela
Sulmetin Spain
Stability of mixtures   Injection   Stability of mixtures : Magnesium sulfate     
Container Solvent Concentration Compound Temperature Storage Duration of stability References
Glass Sodium chloride 0,9% 8 mg/ml
Injection   Magnesium sulfate   
Injection   Granisetron hydrochloride 0,5 mg/ml
20-23°C
4 Hour
Light 57
Level of evidence A+
Glass Sodium chloride 0,9% 15,6 mg/ml
Injection   Magnesium sulfate   
Injection   Heparin sodium 50 UI/ml
25°C
14 Day
Light 2100
Biological analysis
Glass Glucose 5% 30 mg/ml
Injection   Magnesium sulfate   
Injection   Ciclosporin 2 mg/ml
24°C
6 Hour
Light 291
Level of evidence D
Glass Glucose 5% 10 & 20 mg/ml
Injection   Magnesium sulfate   
Injection   Metronidazole 2 mg/ml
25°C
20 Hour
Protect from light 630
Level of evidence D
Glass Glucose 5% 10 & 20 mg/ml
Injection   Magnesium sulfate   
Injection   Cefamandole nafate 5 mg/ml
25°C
20 Hour
Protect from light 630
Level of evidence D
Glass Glucose 5% 10 & 20 mg/ml
Injection   Magnesium sulfate   
Injection   Cefazolin sodium 5 mg/ml
25°C
20 Hour
Protect from light 630
Level of evidence D
Glass Glucose 5% 10 & 20 mg/ml
Injection   Magnesium sulfate   
Injection   Piperacillin sodium 5 mg/ml
25°C
20 Hour
Protect from light 630
Level of evidence D
Glass Glucose 5% 10 & 20 mg/ml
Injection   Magnesium sulfate   
Injection   Cefoxitin sodium 5 mg/ml
25°C
20 Hour
Protect from light 630
Level of evidence D
Glass Glucose 5% 10 & 20 mg/ml
Injection   Magnesium sulfate   
Injection   Moxalactam 5 mg/ml
25°C
20 Hour
Protect from light 630
Level of evidence D
Polyvinyl chloride NaCl 0,9% or Glucose 5% 3,81 & 8,92 mg/ml
Injection   Magnesium sulfate   
Injection   Calcium gluconate 3,81 & 8,92 mg/ml
25°C
7 Day
Protect from light 3268
Polyvinyl chloride NaCl 0,9% or Glucose 5% 3,81 & 8,92 mg/ml
Injection   Magnesium sulfate   
Injection   Calcium gluconate 3,81 & 8,92 mg/ml
5°C
7 Day
Protect from light 3268
Polyvinyl chloride Sodium chloride 0,9% 1,9 mg/ml
Injection   Magnesium sulfate   
Injection   Cisplatin 0,1 mg/ml
Injection   Potassium chloride 2,9 mEq/l
25°C
28 Day
Protect from light 3183
Level of evidence A+
Polyvinyl chloride Glucose 5% 1 & 2 mg/ml
Injection   Magnesium sulfate   
Injection   Cisplatin 0,05 & 0,2 mg/ml
Injection   Mannitol 18,75 mg/ml
-15°C
30 Day
Protect from light 1080
Manufacturer's stability data
Polyvinyl chloride Glucose 5% 1 & 2 mg/ml
Injection   Magnesium sulfate   
Injection   Cisplatin 0,05 & 0,2 mg/ml
Injection   Mannitol 18,75 mg/ml
25°C
48 Hour
Not specified 1080
Manufacturer's stability data
Polyvinyl chloride Glucose 5% 1 & 2 mg/ml
Injection   Magnesium sulfate   
Injection   Cisplatin 0,05 & 0,2 mg/ml
Injection   Mannitol 18,75 mg/ml
4°C
4 Day
Protect from light 1080
Manufacturer's stability data
Polypropylen Syringe None 2 mg/ml
Injection   Magnesium sulfate   
Injection   Lidocaine hydrochloride 455 mg/ml
25°C
168 Day
Protect from light 4457
Level of evidence A
Polypropylen Syringe None 2 mg/ml
Injection   Magnesium sulfate   
Injection   Lidocaine hydrochloride 455 mg/ml
40°C
168 Day
Protect from light 4457
Level of evidence A
  Mentions Légales